CDRH Is Testing New Decision Methods That Could “Change Everything”
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is pursuing a pilot study of "quantitative" methods for evaluating data that some say could be the beginning of a complete overhaul in the way regulatory decisions are made
You may also be interested in...
Postmarket Transformation Plan Update With FDA’s Don St. Pierre
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative
Postmarket Transformation Plan Update With FDA’s Don St. Pierre
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative
No More Secrets: CDRH Post-Approval Study Web Site Goes Live April 6
A public Web site tracking device companies' progress on FDA-required post-approval studies is scheduled to go live April 6